Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts
Crossref DOI link: https://doi.org/10.1186/s12885-025-13460-1
Published Online: 2025-01-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Id Boufker, Hichame
Lagneaux, Laurence
Najar, Mehdi
Piccart, Martine
Ghanem, Ghanem
Body, Jean-Jacques
Journé, Fabrice
Text and Data Mining valid from 2025-01-09
Version of Record valid from 2025-01-09
Article History
First Online: 9 January 2025